Trobix Bio
https://www.trobixbio.com/Overview
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 30, 2023 | Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics | /EIN News/ -- Netanya, Israel, March 30, 2023 - Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision microbiome oncology therapeutics, announced today the successful closing of a US... |
| Jul 31, 2020 | Trobix Bio Closes US$3M Series A Funding | Trobix Innovation Ltd., a Netanya, Israel-based biotechnology company developing therapies to remove the threat of antimicrobial resistance, closed a US $ 3M Series A funding. The round was led by Chartered Opus. The company intends to use ... |
| Trobix Bio | “Empowering engineered phages with CRISPR to modify microbiome for better medicine” |
Reviews 0
FAQ about Trobix Bio
What has the press written about Trobix Bio?
Parsers VC has collected 4 articles mentioning Trobix Bio, among them “Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics” (Mar 30, 2023) and “Trobix Bio Closes US$3M Series A Funding” (Jul 31, 2020).
Is Trobix Bio still active?
Trobix Bio is probably closed: its latest activity on Parsers VC dates from Apr 2, 2023.